Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04041167

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04041167
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04041167. Randomized; no masking; primary purpose treatment. Start 2018-08-01 (actual); primary completion 2021-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)
Condition
Stroke, Ischemic
Intervention (Drug)
alpha lipoic acid
Intervention (Drug)
Saline
Lead sponsor
Chonnam National University Hospital (class: other)
Collaborator
Chosun University Hospital (class: other)
Collaborator
Chonbuk National University Hospital (class: other)
Collaborator
Wonkwang University Hospital (class: other)

Record details

Record id
cardio:ct-nct04041167
Content hash
a39e19e0f14e0b7bc9a665905a3920880e81d55397b6a0eb19e1f0a40e38d733